ARTICLE | Company News
Cerep, AVE medicinal chemistry deal
November 12, 2001 8:00 AM UTC
Cerep (NM:Cerep) will use its medicinal chemistry technologies to optimize small molecule protein kinase inhibitors for Aventis (AVE) on a fee-for-service basis. ...